top of page
ResolveBioLogo-final-09.png
flowsaber_httpss.mj.run4Dl5JWb4NHc_httpss.mj.runX2VjOqvD-pI_htt_6bfc8661-73ad-4ce9-8371-ea

About

Our team of executives, pharmaceutical developers and scientists thrive when tackling big problems from new angles. We have a strong track record of clinical trial success in chronic autoimmune diseases, and we are expanding our pipeline into acute inflammatory diseases to provide new and potentially better treatment options for patients. We are a versatile team that is focused on pursuing new approaches to solve long-standing problems, to provide new treatment options for patients.

Leadership Team

midjourney-editor-1746403709872.png

James Posada, Ph.D.

Founder
Chief Executive Officer
Member, Board of Managers

midjourney-editor-1746404089350.png

Peter Kiener, Ph.D.

Chairman of the Board of Managers

 

resolve headshot (7).jpg

Somu Subramaniam

Member, Board of Managers

 

midjourney-editor-1746405574053.png

Gábor Illei, MD, PhD, MHS

Clinical Strategy Leader

 

Scientific Advisory Board

midjourney-editor-1746406419551.png

Peter Libby, MD
 

Professor of Medicine
Cardiovascular
Harvard Medical School

 

2.png

Tomas Mustelin, MD, Ph.D.

Head, Div. Rheumatology
Univ. of Washington
 

midjourney-editor-1746404089350.png

Peter Kiener, Ph.D.
 

Venture Partner
ICG Life Science
 

1746407229056.png

Nils Lonberg, Ph.D.
 

Executive in Residence
Cannan Partners
 

midjourney-editor-1746408663819.png

Juan Pablo Tosar, Ph.D.
 

Assistant Professor
University of the Republic of Uruguay
Lab Head, Functional Genomics Laboratory
Pasteur Institute of Montevideo
 

bottom of page